Equities

Zentalis Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ZNTL:NMQ

Zentalis Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.39
  • Today's Change0.05 / 2.14%
  • Shares traded245.31k
  • 1 Year change-1.65%
  • Beta1.7082
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income(166)(292)(237)
Depreciation/depletion1.291.391.43
Non-Cash items107859
Cash taxes paid, supplemental0.360.140.01
Cash interest paid, supplemental------
Changes in working capital(17)5.8613
Total cash from operations(171)(208)(164)
INVESTING
Capital expenditures(0.22)(0.58)(2.55)
Other investing and cash flow items, total177(44)(112)
Total cash from investing177(44)(114)
FINANCING
Financing cash flow items(0.24)00
Total cash dividends paid------
Issuance (retirement) of stock, net0.35237261
Issuance (retirement) of debt, net------
Total cash from financing0.11237261
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash5.81(15)(17)
Net cash-begin balance/reserved for future use314663
Net cash-end balance/reserved for future use373146
SUPPLEMENTAL INCOME
Depreciation, supplemental1.291.391.43
Cash interest paid, supplemental------
Cash taxes paid, supplemental0.360.140.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.